ACE and hydrops fetalis: The CardioMEMS HF system was implanted in 1200 NYHA III patients with a HF-related hospitalization within 12 months prior to inclusion and use of betablocker and angiotensin-converting enzyme inhibitor (ACEi)/angiotensin II receptor blocker (ARB) in case of HFrEF.